With nearly 40 years of experience in chitosan R&D, Liu Wanshun is the founder of the chitosan industry, a pioneer in modified chitosan and its industrialization research, and a leader in the marine biomaterials industry. He has received 25 national invention patents, 10 awards including the National Invention Award (Third Class), National Science and Technology Progress Award (Second Class), Ministry of Education Science and Technology Progress Award (Second Class), State Oceanic Administration Science and Technology Progress Award (First Class), and Shandong Province Invention Award (Second Class). He has mentored 138 doctoral and master's students and published 286 research papers.

Mainly engaged in fundamental research and product development of molecular modification of marine biomaterials, functional activities, and their applications in medicine and health. Has undertaken and completed 18 national-level projects including key R&D programs, the 863 Program, National Science and Technology Support Program, and National Science and Technology Major Special Projects, and published over 100 research papers.

Professor Wang Yunbing is the chief technical director and inventor of the world's first approved Abbott polylactic acid fully degradable polymer stent. Recognizing the performance and characteristics of chitosan-based fully degradable vascular stents, he specifically established the only national-level biomaterials innovation research base for collaborative R&D on this key project.